Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI-Visible Nanocarrier Targeting Hepatic Stellate Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI-Visible Nanocarrier Targeting Hepatic Stellate Cells
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 1801809
Publisher
Wiley
Online
2019-01-15
DOI
10.1002/advs.201801809
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Facile synthesis of semi-library of low charge density cationic polyesters from poly(alkylene maleate)s for efficient local gene delivery
- (2018) Huijie Yan et al. BIOMATERIALS
- Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development
- (2018) Yun-Chieh Sung et al. Theranostics
- pH-Sensitive Nanocarrier-Mediated Codelivery of Simvastatin and Noggin siRNA for Synergistic Enhancement of Osteogenesis
- (2018) Jinsheng Huang et al. ACS Applied Materials & Interfaces
- Liver inflammation and fibrosis
- (2017) Yukinori Koyama et al. JOURNAL OF CLINICAL INVESTIGATION
- HOTAIR Epigenetically Modulates PTEN Expression via MicroRNA-29b: A Novel Mechanism in Regulation of Liver Fibrosis
- (2017) Fujun Yu et al. MOLECULAR THERAPY
- Rationally Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer
- (2016) Aaron Goldman et al. ACS Nano
- Suppressive effect of microRNA-29b on hepatic stellate cell activation and its crosstalk with TGF-β1/Smad3
- (2016) Chunli Liang et al. CELL BIOCHEMISTRY AND FUNCTION
- Non-viral nucleic acid containing nanoparticles as cancer therapeutics
- (2016) Kristen L. Kozielski et al. Expert Opinion on Drug Delivery
- Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma
- (2016) Yu Guo et al. HEPATOLOGY
- MicroRNAs in hepatic pathophysiology
- (2016) Yoshiki Murakami et al. HEPATOLOGY RESEARCH
- A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
- (2016) Carla L. Esposito et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-penetrating peptide modified and pH-sensitive polyplexes for tumor targeted siRNA delivery
- (2016) Guoyong Zhou et al. Polymer Chemistry
- Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer
- (2016) Esteban N. Gurzov et al. Small
- MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
- (2016) Jeongeun Hyun et al. Nature Communications
- MiR-125b is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
- (2015) Varun Nagpal et al. CIRCULATION
- Hepatic inflammation and fibrosis: Functional links and key pathways
- (2015) Ekihiro Seki et al. HEPATOLOGY
- Hepatic fibrosis: Concept to treatment
- (2015) Christian Trautwein et al. JOURNAL OF HEPATOLOGY
- MicroRNA regulatory networks in human adipose tissue and obesity
- (2015) Peter Arner et al. Nature Reviews Endocrinology
- Antifibrotic Therapies in the Liver
- (2015) D. Schuppan et al. SEMINARS IN LIVER DISEASE
- The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal Hypertension
- (2015) Hien T. T. Duong et al. Small
- Effective siRNA therapy of hepatoma mediated by a nonviral vector with MRI-visibility and biodegradability
- (2015) Jin Wang et al. RSC Advances
- Drug and gene co-delivery systems for cancer treatment
- (2015) Zhe Yang et al. Biomaterials Science
- A Reduction and pH Dual-Sensitive Polymeric Vector for Long-Circulating and Tumor-Targeted siRNA Delivery
- (2014) Jingguo Li et al. ADVANCED MATERIALS
- Early to Phase II drugs currently under investigation for the treatment of liver fibrosis
- (2014) Peter Hauff et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Novel role of nuclear receptor rev-erbα in hepatic stellate cell activation: Potential therapeutic target for liver injury
- (2014) Ting Li et al. HEPATOLOGY
- miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling
- (2014) Yang Zhang et al. MOLECULAR THERAPY
- Epigenetic Regulation ofmiR-17∼92Contributes to the Pathogenesis of Pulmonary Fibrosis
- (2013) Duaa Dakhlallah et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases
- (2013) Yong He et al. BIOCHIMIE
- The Autoregulatory Feedback Loop of MicroRNA-21/Programmed Cell Death Protein 4/Activation Protein-1 (MiR-21/PDCD4/AP-1) as a Driving Force for Hepatic Fibrosis Development
- (2013) Zhengping Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evolving therapies for liver fibrosis
- (2013) Detlef Schuppan et al. JOURNAL OF CLINICAL INVESTIGATION
- Copolymer of poly(ethylene glycol) and poly(l-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery
- (2013) Jingguo Li et al. Nanoscale
- MicroRNAs in liver disease
- (2013) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- Dissection of Protein Interactomics Highlights MicroRNA Synergy
- (2013) Wenliang Zhu et al. PLoS One
- Recent Developments in Myofibroblast Biology
- (2012) Boris Hinz et al. AMERICAN JOURNAL OF PATHOLOGY
- Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
- (2012) Juliane S. Troeger et al. GASTROENTEROLOGY
- MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis
- (2012) Tomohiro Ogawa et al. GUT
- miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis
- (2012) Christoph Roderburg et al. JOURNAL OF HEPATOLOGY
- miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression
- (2012) Jiang Li et al. JOURNAL OF HEPATOLOGY
- Simultaneous Delivery of siRNA and Paclitaxel via a “Two-in-One” Micelleplex Promotes Synergistic Tumor Suppression
- (2011) Tian-Meng Sun et al. ACS Nano
- Pathogenesis of Liver Fibrosis
- (2011) Virginia Hernandez-Gea et al. Annual Review of Pathology-Mechanisms of Disease
- Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat
- (2011) Du Cheng et al. BIOMATERIALS
- The specificities of small molecule inhibitors of the TGFß and BMP pathways
- (2011) Janis Vogt et al. CELLULAR SIGNALLING
- The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice
- (2011) Yong-Han Paik et al. HEPATOLOGY
- Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor–beta on hepatic fibrosis in rats
- (2011) Feng Li et al. JOURNAL OF CONTROLLED RELEASE
- Suppression of microRNA-29 Expression by TGF- 1 Promotes Collagen Expression and Renal Fibrosis
- (2011) B. Wang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
- (2010) Christoph Roderburg et al. HEPATOLOGY
- Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats
- (2010) Cheng Liu et al. LABORATORY INVESTIGATION
- Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone
- (2008) Yasushi Sato et al. NATURE BIOTECHNOLOGY
- The current state of serum biomarkers of hepatotoxicity
- (2007) Josef Ozer et al. TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation